Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2025-12-24 @ 4:40 PM
NCT ID:
NCT02019966
Eligibility Criteria:
Inclusion Criteria:
* more than 20 years old adults
* chronic hepatitis B
* the patients treated by tenofovir alone or tenofovir based combination therapy because of the previous treatment failure
* the patients who agree and singed on the consent form
Exclusion Criteria:
* co-infected patients with HCV, HDV or HIV
* pregnancy or breast feeding woman or female patients who are planning to be pregnant
* past history with hepatocellular carcinoma
* combined with other liver disease including wilson, alcoholic, NASH, alpha-1 antitrypsin deficiency liver disease.
* patients with hypersensitivity for drugs
* patients who were enrolled in other clinical study within 60 days
* patients who were eligible for the clinical study according to the investor
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT02019966
Study Brief:
Protocol Section:
NCT02019966